Nektar Therapeutics (NKTR) Tops Q3 EPS by 4c
Get Alerts NKTR Hot Sheet
Price: $0.93 +4.49%
Revenue Growth %: -32.9%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
FSI, RELV, NEOM, More
Revenue Growth %: -32.9%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $36.3 million versus the consensus estimate of $32.42 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Pineapple Energy Inc. (PEGY) Misses Q4 EPS by 8c
- TSS, Inc. (TSSI) Reports Q4 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!